Estimaciones de analistas de Wall Street para Adaptimmune Therapeutics plc (ADAP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 9 |
| Mantener | 4 |
| Venta | 3 |
| Venta fuerte | 0 |
| Analistas totales | 16 |
| Calificación media (1-5) | 0.38 |
Ratios de valoración
| Precio / Valor contable | -0.18 |
| EV / EBITDA | -1.42 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $10.7M | $14.2M | $37.8M | $59.5M | $1.1M | $4.0M | $6.1M | $27.1M | $60.3M | $178.0M |
| Coste de Ventas | 0 | 0 | 0 | 0 | $97.5M | $91.6M | $111.1M | $127.7M | $9.9M | $70000 |
| Beneficio Bruto | $10.7M | $14.2M | $37.8M | $59.5M | -$96.4M | -$87.6M | -$104.9M | -$100.6M | $50.4M | $178.0M |
| I+D | $23.2M | $63.8M | $87.4M | $98.3M | $97.5M | $91.6M | $111.1M | $127.7M | $126.5M | $149.1M |
| Generales y Administrativos | $11.3M | $23.2M | $31.1M | $43.6M | $43.4M | $45.8M | $57.3M | $63.4M | $71.8M | $81.3M |
| Gastos Operativos | $33.8M | $87.0M | $118.5M | $141.9M | $140.9M | $137.4M | $168.4M | $191.1M | $188.4M | $246.7M |
| Beneficio Operativo | -$23.1M | -$72.8M | -$80.7M | -$82.4M | -$139.8M | -$133.4M | -$162.2M | -$164.0M | -$138.0M | -$68.8M |
| EBITDA | -$23.8M | -$69.5M | -$75.2M | -$74.6M | -$131.8M | -$125.8M | -$155.7M | -$155.6M | -$128.2M | -$52.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.3M |
| Beneficio Antes de Impuestos | -$23.7M | -$70.7M | -$69.7M | -$95.0M | -$136.9M | -$129.9M | -$157.3M | -$163.0M | -$112.5M | -$67.3M |
| Impuestos | -$2.1M | $892000 | $451000 | $497000 | $242000 | $162000 | $791000 | $2.5M | $1.3M | $3.6M |
| Beneficio Neto | -$21.6M | -$71.6M | -$70.1M | -$95.5M | -$137.2M | -$130.1M | -$158.1M | -$165.5M | -$113.9M | -$70.8M |
| BPA | $-0.60 | $-1.02 | $-0.78 | $-0.96 | $-1.32 | $-0.90 | $-1.02 | $-1.02 | $-0.57 | $-0.28 |
| BPA Diluido | $-0.60 | $-1.02 | $-0.78 | $-0.96 | $-1.32 | $-0.90 | $-1.02 | $-1.02 | $-0.57 | $-0.28 |
| Acciones en Circulación (Diluidas) | $35.8M | $70.8M | $87.9M | $97.4M | $105.0M | $142.5M | $155.8M | $161.2M | $201.1M | $252.3M |
Precio
| Precio | $0.05 |
| Capitalización | $75M |
| Bolsa | NASDAQ |
| País | GB |
Empresas relacionadas: ANL · APLM · BLRX · ERNA · GOVX · LNAI · LPCN
Explorar sector: Healthcare · Biotechnology
Más secciones de ADAP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones